150 related articles for article (PubMed ID: 1841544)
1. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
Siemion IZ; Słoń J; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
[TBL] [Abstract][Full Text] [Related]
2. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
[TBL] [Abstract][Full Text] [Related]
3. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
Paradowski A; Dynowski Z; Kubik A; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
[TBL] [Abstract][Full Text] [Related]
4. Competition between tuftsin and HBV S-protein sequences.
Siemion IZ; Słoń J; Nawrocka E; Wieczorek Z
Int J Pept Protein Res; 1990 May; 35(5):428-33. PubMed ID: 2376468
[TBL] [Abstract][Full Text] [Related]
5. The influence of tuftsin partial sequences on histamine level in guinea pig and rat tissues.
Paradowski A; Rózga M; Wronowska G; Nawrocka-Bolewska E; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):207-12. PubMed ID: 1300985
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
[TBL] [Abstract][Full Text] [Related]
7. The evidence on the possible interleukin-1 alpha tuftsin competition.
Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
[TBL] [Abstract][Full Text] [Related]
8. Further investigations on the antinociceptive activity of tuftsin analogs.
Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
[TBL] [Abstract][Full Text] [Related]
9. Stability of sterile saline solutions of synthetic tuftsin, a naturally occurring immunomodulating peptide.
Nishioka K; Dessens SE; Rodriguez T
Pept Res; 1991; 4(4):230-3. PubMed ID: 1823602
[TBL] [Abstract][Full Text] [Related]
10. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. II. Hexapeptide Gly-Pro- Gly-Arg-Ala-Phe].
Andrianov AM
Mol Biol (Mosk); 1997; 31(5):872-9. PubMed ID: 9454073
[No Abstract] [Full Text] [Related]
11. Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. A two-signal progenitor restricted, tuftsin-like effect.
Moore RN; Osmand AP; Dunn JA; Joshi JG; Rouse BT
J Immunol; 1988 Oct; 141(8):2699-703. PubMed ID: 2459223
[TBL] [Abstract][Full Text] [Related]
12. [Molecular mechanisms of action of dendrons, containing 48-60 sequence of HIV-1 TAT-protein, on the functional activity of the adenylyl cyclase signaling systems].
Shpakov AO; Gur'ianov IA; Avdeeva EV; Vorob'ev VI; Vlasov GP
Tsitologiia; 2004; 46(11):1011-22. PubMed ID: 15704884
[TBL] [Abstract][Full Text] [Related]
13. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
Zvi A; Feigelson DJ; Hayek Y; Anglister J
Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppressive activity of analogs of tripeptide Lys-Arg-Pro with D-amino acid residues.
Siemion IZ; Kluczyk A; Słoń JJ; Zimecki M; Wieczorek Z
Arch Immunol Ther Exp (Warsz); 1994; 42(3):205-7. PubMed ID: 7487354
[TBL] [Abstract][Full Text] [Related]
15. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric identification of the trypsin cleavage pathway in lysyl-proline containing oligotuftsin peptides.
Manea M; Mezo G; Hudecz F; Przybylski M
J Pept Sci; 2007 Apr; 13(4):227-36. PubMed ID: 17394121
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraperitoneal tuftsin administration on histamine concentration in tissues of guinea-pigs.
Paradowski A; Rózga M; Nawrocka E; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):153-7. PubMed ID: 1804046
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory activity of conformationally restricted peptides related to TGF-beta-2 90-99 sequence.
Wieczorek Z; Słoń JJ; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1996; 44(4):209-14. PubMed ID: 9017160
[TBL] [Abstract][Full Text] [Related]
19. [Theoretical study of the spatial structure of the Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr segment of the HIV gp120 protein, responsible for binding of the virus with the T-cell T4 receptor].
Andrianov AM; Akhrem AA
Mol Biol (Mosk); 1997; 31(1):180-8. PubMed ID: 9173240
[No Abstract] [Full Text] [Related]
20. Influence of the peptide chain length of new elongated tuftsin analogs on phagocytosis process.
Konopińska D; Kazanowska B; Bogusławska-Jaworska J
Int J Pept Protein Res; 1984 Sep; 24(3):267-73. PubMed ID: 6594319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
